Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    "Klebsiella"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
Conditions: Quinolone Resistance;   ESBL;   Klebsiella Species;   Infection
2 Unknown  Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
Conditions: Anti-Biotic Resistance;   Klebsiella Pneumoniae
Interventions: Dietary Supplement: VSL#3;   Drug: Polyethylene glycol
3 Completed Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
Conditions: Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: vancomycin-resistant enterococci and ESBL
4 Recruiting Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
Conditions: Escherichia Coli Infections;   Klebsiella Pneumonia
5 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
6 Unknown  SDD for Eradicating CRKP Carriage
Condition: Carriers of Carbapenem-resistant Klebsiella Pneumonia
Intervention: Device: Gentamicin and polymyxin E
7 Active, not recruiting Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Conditions: Infection;   E Coli Infections;   Klebsiella Infections;   Proteus Infections
8 Completed Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features
Condition: Necrotizing Fasciitis
9 Recruiting Antibiotics for Klebsiella Liver Abscess Study
Condition: Liver Abscess, Pyogenic
Interventions: Drug: Ciprofloxacin;   Drug: Ceftriaxone;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Ertapenem
10 Unknown  A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Condition: Patients Diagnosed With Concomitant KPC Associated Disease ,Bacteremia, Pneumonia.
Interventions: Drug: Colistin (Polymyxin E) 100mg x 4/d;   Drug: both medications;   Drug: will not receive PO treatment;   Drug: PO Garamycin 80mg x 4/d
11 Completed Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
Condition: Carriage of Carbapemen-resistant Klebsialle Pneumoniae
Intervention: Drug: Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.
12 Recruiting Trial to Compare Piperacillin-tazobactam to Meropenem for the Definitive Treatment of Bloodstream Infections Caused by Ceftriaxone Resistant E. Coli or Klebsiella Species.
Condition: Bloodstream Infections
Interventions: Drug: Meropenem;   Drug: Piperacillin-tazobactam combination product
13 Unknown  Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
Condition: Infections
Intervention: Drug: Colistin
14 Completed The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Condition: End-stage Renal Disease
Intervention: Other: renal replacement therapy
15 Enrolling by invitation Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis
Condition: Community Acquired Infection
Intervention: Other: bacteremia caused by ESBL producing E.coli or K.pneumoniae
16 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline
17 Terminated Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Conditions: Benign Airway Disease;   Sarcoidosis;   Wegener's Granulomatosis;   Rhinoscleroma;   Recurrent Respiratory Papillomatosis(RRP)
Intervention: Device: CryoSpray Ablation (tm)
18 Recruiting Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)
Condition: Bacteremia
19 Completed Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
Condition: Drug Resistance, Microbial
Intervention: Other: None - Observational study

Indicates status has not been verified in more than two years